Total submissions: 4
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV002146475 | SCV002465917 | likely benign | Autosomal recessive polycystic kidney disease | 2024-03-01 | criteria provided, single submitter | clinical testing | |
Gene |
RCV004729097 | SCV005331855 | uncertain significance | not provided | 2023-07-18 | criteria provided, single submitter | clinical testing | In silico analysis supports that this missense variant does not alter protein structure/function; Has not been previously published as pathogenic or benign to our knowledge |
Fulgent Genetics, |
RCV005042744 | SCV005671363 | uncertain significance | Polycystic kidney disease 4 | 2024-05-02 | criteria provided, single submitter | clinical testing | |
Prevention |
RCV003916325 | SCV004730067 | uncertain significance | PKHD1-related disorder | 2024-01-18 | no assertion criteria provided | clinical testing | The PKHD1 c.4558G>A variant is predicted to result in the amino acid substitution p.Val1520Met. To our knowledge, this variant has not been reported in the literature. This variant is reported in 0.12% of alleles in individuals of Ashkenazi Jewish descent in gnomAD (http://gnomad.broadinstitute.org/variant/6-51890050-C-T). At this time, the clinical significance of this variant is uncertain due to the absence of conclusive functional and genetic evidence. |